PK and PD Study of IDN-6556 in Subjects With Hepatic Impairment and Matched Healthy Volunteers
NCT02121860
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
37
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatic Impairment
Liver Diseases
Digestive System Diseases
Interventions
DRUG:
IDN-6556
Sponsor
Conatus Pharmaceuticals Inc.